Literature DB >> 28781798

Paraneoplastic limbic encephalitis with late-onset magnetic resonance imaging findings: A case report.

Yoshiya Tsunoda1, Takumi Kiwamoto1, Shinsuke Homma1, Yuuki Yabuuchi1, Haruna Kitazawa1, Toshihiro Shiozawa1, Kensuke Nakazawa1, Takashi Hosaka2, Kazuhiro Ishii2, Akiko Ishii2, Akira Tamaoka2, Nobuyuki Hizawa1.   

Abstract

Paraneoplastic limbic encephalitis (PLE), a paraneoplastic neurological syndrome (PNS), is a rare nervous system disorder that results from the indirect effects of tumors and is commonly associated with small-cell lung cancer (SCLC). Previous studies have reported that magnetic resonance imaging (MRI) may be useful for diagnosing LE. Temporal lobe abnormalities are observed using T2-weighted and fluid-attenuated inversion recovery sequences; however, such abnormalities are detected in only 60% of patients with PLE. The present study describes a case of PLE associated with SCLC, in which LE was observed using MRI 26 days after the first convulsive seizure. Although the serum and cerebrospinal fluid analyses for onconeural antibodies were negative, the findings of this case indicate that PLE should be considered in the differential diagnosis, and that repeated brain MRI may be more helpful for diagnosis, as the brain MRI findings may be normal during the early stages of PLE.

Entities:  

Keywords:  magnetic resonance imaging; onconeural antibody; paraneoplastic limbic encephalitis; paraneoplastic neurological syndromes; small-cell lung cancer

Year:  2017        PMID: 28781798      PMCID: PMC5532705          DOI: 10.3892/mco.2017.1311

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  13 in total

1.  Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

Authors:  W P Mason; F Graus; B Lang; J Honnorat; J Y Delattre; F Valldeoriola; J C Antoine; M K Rosenblum; M R Rosenfeld; J Newsom-Davis; J B Posner; J Dalmau
Journal:  Brain       Date:  1997-08       Impact factor: 13.501

2.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  J E Greenlee
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 3.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

4.  Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.

Authors:  Bruno Giometto; Wolfgang Grisold; Roberta Vitaliani; Francesc Graus; Jérôme Honnorat; Guido Bertolini
Journal:  Arch Neurol       Date:  2010-03

5.  Paraneoplastic neurologic disorders in small cell lung carcinoma: A prospective study.

Authors:  Paul Gozzard; Mark Woodhall; Caroline Chapman; Anjan Nibber; Patrick Waters; Angela Vincent; Bethan Lang; Paul Maddison
Journal:  Neurology       Date:  2015-06-24       Impact factor: 9.910

6.  Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates.

Authors:  Beau M Ances; Roberta Vitaliani; Robert A Taylor; David S Liebeskind; Alfredo Voloschin; David J Houghton; Steven L Galetta; Marc Dichter; Abass Alavi; Myrna R Rosenfeld; Josep Dalmau
Journal:  Brain       Date:  2005-05-11       Impact factor: 13.501

Review 7.  Paraneoplastic epilepsy.

Authors:  Anna Serafini; Rimas V Lukas; Stephen VanHaerents; Peter Warnke; James X Tao; Sandra Rose; Shasha Wu
Journal:  Epilepsy Behav       Date:  2016-06-12       Impact factor: 2.937

Review 8.  Which antibody and which cancer in which paraneoplastic syndromes?

Authors:  Paul Gozzard; Paul Maddison
Journal:  Pract Neurol       Date:  2010-10

Review 9.  Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis.

Authors:  Rainer Scheid; Thomas Lincke; Raymond Voltz; D Yves von Cramon; Osama Sabri
Journal:  Arch Neurol       Date:  2004-11

10.  Serial MRI of limbic encephalitis.

Authors:  Horst Urbach; Bettina M Soeder; Monika Jeub; Thomas Klockgether; Bernhard Meyer; Christian G Bien
Journal:  Neuroradiology       Date:  2006-04-04       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.